Discovery of novel oxazepine and diazepine carboxamides as two new classes of heat shock protein 90 inhibitors.Neubert, T., Numa, M., Ernst, J., Clemens, J., Krenitsky, P., Liu, M., Fleck, B., Woody, L., Zuccola, H., Stamos, D.
(2015) Bioorg Med Chem Lett 25: 1338-1342
- PubMed: 25677667
- DOI: https://doi.org/10.1016/j.bmcl.2015.01.023
- Primary Citation of Related Structures:
4XIP, 4XIQ, 4XIR, 4XIT
- PubMed Abstract:
Two novel series of oxazepine and diazepine based HSP90 inhibitors are reported. This effort relied on structure based design and isothermal calorimetry to identify small drug like macrocycles. Computational modelling was used to build into a solvent exposed pocket near the opening of the ATP binding site, which led to potent inhibitors of HSP90 (25-30).
Vertex Pharmaceuticals Incorporated, Department of Structural Biology, 50 Northern Avenue, Boston, MA 02210, United States.